Understanding China's Regional Healthcare Markets

Published 29 May 2015

  • 203 pages
  • Instant access to your report in PDF format through your account library
$935.00
Understanding China's Regional Healthcare Markets

BMI View: As the world's most populous country gradually shifts towards universal healthcar e, many commercial players ( pharmaceutic al firms, healthcare providers and medical device manufacturers amongst others ) will benefit from healthcare reform . H ealthy economic growth, a growing middle class population and high wages are helping to fuel the development of the private healthcare sector . However, rising medical costs and disparate access to healthcare services remain the Chinese peoples' main concerns , and the government will gradually address these issues.

Since the start of the healthcare reform programme in 2009, China has progressively improved healthcare standards and introduced various policies to strengthen the link between healthcare, healthcare insurance and pharmaceutical provision; enhance public healthcare services; further develop medical care to benefit patients; boost the morale of medical professionals by improving working conditions, particularly in rural and remote regions; speed up public healthcare reform; further reduce foreign ownership restrictions in joint venture medical institutions; improve regulation of the pharmaceutical supply chain; and crack down on illegal activities to prevent drug price escalation. China's Premier Li Keqiang has reiterated these aims recently through written instructions on April 29 2015, calling for further medical reforms to ensure that China's healthcare system is improved on the back of the country's economic development plan.

Key aims for 2015 are to cut down on hospitals' reliance on drug sales as a source of income, improve the private sector's presence in the market and introduce a multi-tiered system of diagnosis for patients. This is on the back of the central government's longer term plans to increase health expenditure to 6.5-7.0% of GDP by 2020 to achieve 10 targets. These include improving a number of key health indicators: increase average life expectancy to 77...

Espicom’s Understanding China's Regional Healthcare Markets Report allows you to explore China’s regional markets by giving you a practical evaluation of opportunity and risk at the under-appreciated sub-national level.

Rich in statistics, charts and maps, this is the one report you need to fully appreciate the China’s diverse regional health environments in the context of neighbouring provinces/states/territories and the national picture.

Written in association with Business Monitor International, this unique report uses data sourced in-house, providing analysis and forecasts from our experts covering key areas such as:

  • Healthcare Expenditure
  • Healthcare Facilities
  • Healthcare Personnel
  • Demographics
  • Economic Activity

Published by Espicom - experts in the pharmaceutical, medical devices and healthcare field for over 30 years, Espicom’s Understanding China's Regional Healthcare Markets Report brings together a range of often difficult to source information in one single, convenient and comprehensive publication.

secure
Benefit from discounts when you add multiple products to your basket
2 Products SAVE 10%
3 Products SAVE 15%
4 Products SAVE 20%
5 Products SAVE 25%
6 Products SAVE 30%
7 - 20 Products SAVE 35%
21 Products or more SAVE 40%